Joan R. Kanter

951 total citations
16 papers, 757 citations indexed

About

Joan R. Kanter is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Joan R. Kanter has authored 16 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Joan R. Kanter's work include Computational Drug Discovery Methods (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Joan R. Kanter is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Joan R. Kanter collaborates with scholars based in United States, France and Netherlands. Joan R. Kanter's co-authors include Laurence L. Brunton, Palmer Taylor, Susan S. Taylor, Michael J. Moore, Paul A. Insel, Lingzhi Zhang, Elizabeth J. Ackermann, Randa Hilal-Dandan, Michael J. Watson and Igor F. Tsigelny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation Research.

In The Last Decade

Joan R. Kanter

16 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan R. Kanter United States 13 547 123 83 82 72 16 757
Alison H. Varghese United States 11 476 0.9× 174 1.4× 60 0.7× 46 0.6× 100 1.4× 15 958
Corinne E. Augelli‐Szafran United States 21 599 1.1× 81 0.7× 117 1.4× 221 2.7× 175 2.4× 62 1.1k
Karen Ackermann United States 16 549 1.0× 143 1.2× 24 0.3× 65 0.8× 77 1.1× 24 1.1k
N Kajikawa Japan 9 610 1.1× 60 0.5× 34 0.4× 71 0.9× 122 1.7× 14 909
Stan Tsing United States 10 270 0.5× 215 1.7× 24 0.3× 70 0.9× 35 0.5× 10 627
Manjunath Ramarao United States 13 445 0.8× 97 0.8× 23 0.3× 46 0.6× 129 1.8× 22 693
Eduardo Domínguez Spain 17 387 0.7× 94 0.8× 27 0.3× 130 1.6× 79 1.1× 41 911
D. Zevin‐Sonkin Israel 15 670 1.2× 295 2.4× 103 1.2× 38 0.5× 80 1.1× 25 943
Craig H. Miller United States 13 357 0.7× 139 1.1× 40 0.5× 141 1.7× 56 0.8× 17 717
Alban Girault France 16 648 1.2× 47 0.4× 69 0.8× 55 0.7× 150 2.1× 28 949

Countries citing papers authored by Joan R. Kanter

Since Specialization
Citations

This map shows the geographic impact of Joan R. Kanter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan R. Kanter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan R. Kanter more than expected).

Fields of papers citing papers by Joan R. Kanter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan R. Kanter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan R. Kanter. The network helps show where Joan R. Kanter may publish in the future.

Co-authorship network of co-authors of Joan R. Kanter

This figure shows the co-authorship network connecting the top 25 collaborators of Joan R. Kanter. A scholar is included among the top collaborators of Joan R. Kanter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan R. Kanter. Joan R. Kanter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Keshwani, Malik M., Joan R. Kanter, Yuliang Ma, et al.. (2015). Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system. Proceedings of the National Academy of Sciences. 112(41). 12681–12686. 12 indexed citations
2.
Weinstain, Roy, Joan R. Kanter, Beth Friedman, et al.. (2013). Fluorescent Ligand for Human Progesterone Receptor Imaging in Live Cells. Bioconjugate Chemistry. 24(5). 766–771. 15 indexed citations
3.
Zhang, Lingzhi, Fiona Murray, Laura Z. Rassenti, et al.. (2010). Cyclic nucleotide phosphodiesterase 7B mRNA: An unfavorable characteristic in chronic lymphocytic leukemia. International Journal of Cancer. 129(5). 1162–1169. 14 indexed citations
4.
Zhang, Lingzhi, Fiona Murray, Anja Zahno, et al.. (2008). Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences. 105(49). 19532–19537. 83 indexed citations
5.
Zambon, Alexander C., Lingzhi Zhang, Simon Minovitsky, et al.. (2005). Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. Proceedings of the National Academy of Sciences. 102(24). 8561–8566. 104 indexed citations
6.
Moore, Michael J., et al.. (2002). Phosphorylation of the Catalytic Subunit of Protein Kinase A. Journal of Biological Chemistry. 277(49). 47878–47884. 106 indexed citations
7.
Hilal-Dandan, Randa, Joan R. Kanter, & Laurence L. Brunton. (2000). Characterization of G-protein Signaling in Ventricular Myocytes From the Adult Mouse Heart: Differences From the Rat. Journal of Molecular and Cellular Cardiology. 32(7). 1211–1221. 48 indexed citations
8.
Osaka, Hitoshi, Siobhan Malany, Joan R. Kanter, Steven M. Sine, & Palmer Taylor. (1999). Subunit Interface Selectivity of the α-Neurotoxins for the Nicotinic Acetylcholine Receptor. Journal of Biological Chemistry. 274(14). 9581–9586. 37 indexed citations
9.
Ackermann, Elizabeth J., et al.. (1998). Identification of Pairwise Interactions in the α-Neurotoxin-Nicotinic Acetylcholine Receptor Complex through Double Mutant Cycles. Journal of Biological Chemistry. 273(18). 10958–10964. 62 indexed citations
10.
Marchot, P., Joan R. Kanter, Shelley Camp, et al.. (1997). Expression and Activity of Mutants of Fasciculin, a Peptidic Acetylcholinesterase Inhibitor from Mamba Venom. Journal of Biological Chemistry. 272(6). 3502–3510. 34 indexed citations
11.
Marchot, P., Raimond B. G. Ravelli, Mia L. Raves, et al.. (1996). Soluble monomeric acetylcholinesterase from mouse: Expression, purification, and crystallization in complex with fasciculin. Protein Science. 5(4). 672–679. 50 indexed citations
12.
Koide, Kazunori, Mark E. Bunnage, Luigi Gomez Paloma, et al.. (1995). Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol. Chemistry & Biology. 2(9). 601–608. 52 indexed citations
13.
Kanter, Joan R., et al.. (1991). Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.. Circulation Research. 68(4). 1070–1079. 73 indexed citations
15.
Kanter, Joan R., Lee R. Hagey, & Laurence L. Brunton. (1989). Inhibition of cyclic AMP efflux by insect pheromones and fatty acids. FEBS Letters. 244(1). 149–153. 9 indexed citations
16.
Watson, Michael J., et al.. (1989). Inhibition of Phorbol Ester Binding and Protein Kinase C Activity by Heavy Metals. Journal of Biological Chemistry. 264(10). 5581–5585. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026